SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-151812
Filing Date
2022-05-16
Accepted
2022-05-16 16:27:16
Documents
15
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d334702d8k.htm   iXBRL 8-K 25935
2 EX-99.1 d334702dex991.htm EX-99.1 69106
6 GRAPHIC g334702g0514073932318.jpg GRAPHIC 1830
7 GRAPHIC g334702g0514073932553.jpg GRAPHIC 1876
  Complete submission text file 0001193125-22-151812.txt   231297

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20220516.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20220516_lab.xml EX-101.LAB 17912
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20220516_pre.xml EX-101.PRE 11240
9 EXTRACTED XBRL INSTANCE DOCUMENT d334702d8k_htm.xml XML 3338
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 22929643
SIC: 2834 Pharmaceutical Preparations